Descriptor English: | Lipoproteins, HDL | ||||||
Descriptor Spanish: |
Lipoproteínas HDL
| ||||||
Descriptor Portuguese: | Lipoproteínas HDL | ||||||
Descriptor French: | Lipoprotéines HDL | ||||||
Entry term(s): |
Density Lipoprotein, High HDL Lipoproteins Heavy Lipoproteins High Density Lipoprotein High Density Lipoproteins High-Density Lipoprotein High-Density Lipoproteins Lipoprotein, High Density Lipoprotein, High-Density Lipoproteins, Heavy Lipoproteins, High-Density alpha Lipoprotein alpha Lipoproteins alpha-1 Lipoprotein alpha-Lipoprotein alpha-Lipoproteins |
||||||
Tree number(s): |
D10.532.432 D12.776.521.479 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D008075 | ||||||
Scope note: | A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. |
||||||
Annotation: | hyperalphalipoproteinemia = LIPOPROTEINS, HDL /blood (IM) + HYPERLIPOPROTEINEMIAS (IM); hypoalphalipoproteinemia = LIPOPROTEINS, HDL /blood (IM) + HYPOLIPOPROTEINEMIAS (IM); familial hypoalphalipoproteinemia = TANGIER DISEASE; /defic: consider also HYPOLIPOPROTEINEMIAS |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Previous Indexing: |
Lipoproteins (1966-1971) |
||||||
Public MeSH Note: | 74 |
||||||
History Note: | 74(72) |
||||||
Related: |
Tangier Disease
MeSH | ||||||
DeCS ID: | 8249 | ||||||
Unique ID: | D008075 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1974/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2020/05/27 |
-
-
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Lipoproteins, HDL
- Preferred
alpha-1 Lipoprotein
- Narrower
Concept UI |
M0012584 |
Scope note | A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. |
Preferred term | Lipoproteins, HDL |
Entry term(s) |
Density Lipoprotein, High HDL Lipoproteins Heavy Lipoproteins High Density Lipoprotein High Density Lipoproteins High-Density Lipoprotein High-Density Lipoproteins Lipoprotein, High Density Lipoprotein, High-Density Lipoproteins, Heavy Lipoproteins, High-Density alpha Lipoprotein alpha Lipoproteins alpha-Lipoprotein alpha-Lipoproteins |
Concept UI |
M0012582 |
Preferred term | alpha-1 Lipoprotein |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey